Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Q1 2025 CME Group Inc Earnings Call

In This Article:

Participants

Adam Minick; Director of corporate strategy; CME Group Inc

Terrence Duffy; Executive Chairman of the Board, Chief Executive Officer; CME Group Inc

Suzanne Sprague; Senior Managing Director - Global Head of Clearing and Post-Trade Services for CME Group; CME Group Inc

Sunil Cutinho; Chief Information Officer; CME Group Inc

Lynne Fitzpatrick; Chief Financial Officer; CME Group Inc

Derek Sammann; Senior Managing Director - Global Head of Commodities and Options and International Markets; CME Group Inc

Julie Winkler; Senior Managing Director - Chief Commercial Officer; CME Group Inc

Unidentified Corporate Participant

Kyle Voigt; Analyst; KBW

Dan Fannon; Analyst; Jefferies

Patrick Moley; Analyst; Piper Sandler

Ken Worthington; Analyst; JPMorgan

Ben Budish; Analyst; Barclays.

William Katz; Analyst; TD Cowen

Owen Lau; Analyst; Oppenheimer.

Alex Kramm; Analyst; UBS

Craig Siegenthaler; Analyst; Bank of America

Brian Bedell; Analyst; Deutsche Bank.

Alex Blostein; Analyst; Goldman Sachs

Ashish Sabadra; Analyst; RBC Capital Markets

Chris Allen; Analyst; Citi.

Simon Clinch; Analyst; Redburn Atlantic.

Presentation

Operator

Welcome to the CME Group first quarter 2025 earnings call. (Operator Instructions) I would now like to turn the call over to Adam Minick. Please go ahead.

Adam Minick

Good morning. I hope you're all doing well today. We released our executive commentary earlier this morning, which provides extensive details on the first quarter 2025, which we will be discussing on this call. I'll start with the safe harbor language, and then I'll turn it over to Terry. Statements made on this call and in the other reference documents on our website that are not historical facts are forward-looking statements.
These statements are not guarantees of future performance. They involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any statement. Detailed information about factors that may affect our performance can be found in the filings with the SEC, which are on our website. .
Lastly, in the earnings release, you will see a reconciliation between GAAP and non-GAAP measures following the financial statements.
With that, I'll turn the call over to Terry.

Terrence Duffy

Thanks, Adam, and thank you all for joining us this morning. I'm going to make a few brief comments about our record quarter and the current business environment. And then I'm going to ask Suzanne and Sunil to comment on our market operations during this high volatility environment. Following that, Lynne will provide an overview of our first quarter results. In addition to Suzanne, Sunil and Lynne, we have other members of our management team present to answer questions after the prepared remarks.
This quarter represented the highest volume revenue, operating income and diluted earnings per share in the history of CME Group. Our quarterly revenue crossed $1.6 billion for the first time, and we also exceeded $1 billion in adjusted net income. Our record-breaking performance in the first quarter demonstrated the growing need for risk management globally. The first quarter average daily volume of 29.8 million contracts, not only was the highest quarterly ADV and CME Group's history, it also increased 13% compared to the same period last year.
This strong growth was broad-based with year-over-year volume growth in all 6 asset classes, including all-time quarterly volume records in interest rates, equities, agricultural commodities and foreign exchange. In aggregate, our commodity sector volumes grew by 19%, and our financial products grew by 12%. This quarter highlighted the strength of our product diversity and the ability to customers or customers to manage risk and times of uncertainty.
It also reinforces our past comments about the importance of deep liquidity, especially in times of market stress. This was also a record quarter for our international business, which averaged 8.8 million contracts per day, up 19% from the prior year. This strength was driven by growth across all asset classes and including quarterly volume records in both EMEA and APAC. We also continue to innovate and evolve our product offerings to meet risk management needs for our clients. We recently announced several new offerings that will create opportunities for stronger links between cash and futures markets.
Later this year, we plan to launch BrokerTec Chicago, a central limit order book for cash US treasuries that will be co-located next to our US Treasury futures and options markets. Thus last week we launched FX Spot Plus, which enables spot FX participants to tap in the CME FX future liquidity and gives FX futures users broader access to OTC liquidity.
Looking forward, we continue to see very strong volumes to start the second quarter as market participants look to hedge exposures to tariff policies and geopolitical dynamics. Our open interest today is 7% higher than at the same point last year with strong open interest growth and our interest rate energy and agricultural complexes. This strong open interest trends tend to indicate that despite the high level of volatility market participants are not leaving the market or rather continuing to use our products to manage their risk exposures.
Risk management and resiliency is paramount at CME Group. With record activity this past quarter leading into April, I'm going to ask Suzanne Sprague to give you an update on margins and Sunil Cutinho to give you some color on our resiliency during some of the most unprecedented times that we have seen.
With that, I'm going to turn the call over to Suzanne.